0001127602-23-003336.txt : 20230203
0001127602-23-003336.hdr.sgml : 20230203
20230203163244
ACCESSION NUMBER: 0001127602-23-003336
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230202
FILED AS OF DATE: 20230203
DATE AS OF CHANGE: 20230203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PELUSO MICHELLE A
CENTRAL INDEX KEY: 0001271739
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01011
FILM NUMBER: 23586515
MAIL ADDRESS:
STREET 1: 3150 SABRE DRIVE
CITY: SOUTHLAKE
STATE: TX
ZIP: 76092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CVS HEALTH Corp
CENTRAL INDEX KEY: 0000064803
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
IRS NUMBER: 050494040
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
BUSINESS PHONE: 4017651500
MAIL ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CAREMARK CORP
DATE OF NAME CHANGE: 20070509
FORMER COMPANY:
FORMER CONFORMED NAME: CVS/CAREMARK CORP
DATE OF NAME CHANGE: 20070322
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CORP
DATE OF NAME CHANGE: 19970128
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-02-02
0000064803
CVS HEALTH Corp
CVS
0001271739
PELUSO MICHELLE A
1 CVS DRIVE
WOONSOCKET
RI
02895
1
EVP and Co-President of Retail
Common Stock
2023-02-02
4
A
0
192554
0
A
207465
D
Common Stock (restricted)
82563
D
Stock Option
74.30
2022-04-01
2031-04-01
Common Stock
86386
86386
D
Stock Option
101.09
2023-04-01
2032-04-01
Common Stock
57172
57172
D
Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 26, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 2, 2023.
Consists of Restricted Stock Unit awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 02/26/2022.
Option became exercisable in four equal annual installments, commencing 4/1/2022.
Option becomes exercisable in four equal annual installments, commencing 4/1/2023.
/s/ Michelle A. Peluso
2023-02-03